BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1471 related articles for article (PubMed ID: 18249467)

  • 41. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
    Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of p53 is a late event in the development of malignant melanoma.
    Lassam NJ; From L; Kahn HJ
    Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of melanoma precursor lesions.
    Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
    Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
    Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
    Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of estrogen receptors in dysplastic nevi and malignant melanoma.
    Lecavalier MA; From L; Gaid N
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):242-6. PubMed ID: 2212119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of minichromosome maintenance 2, Ki-67, and geminin in oral nevi and melanoma.
    de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; de Almeida OP
    Ann Diagn Pathol; 2013 Feb; 17(1):32-6. PubMed ID: 22652151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JARID1B expression in human melanoma and benign melanocytic skin lesions.
    Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oestrogen receptor-beta expression in melanocytic lesions.
    Schmidt AN; Nanney LB; Boyd AS; King LE; Ellis DL
    Exp Dermatol; 2006 Dec; 15(12):971-80. PubMed ID: 17083364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations.
    Kim JC; Murphy GF
    Clin Lab Med; 2000 Dec; 20(4):691-712. PubMed ID: 11221510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
    Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
    Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.